Skip to main content
Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc. — Investor Relations & Filings

Ticker · TYRA ISIN · US90240B1061 US Professional, scientific and technical activities
Open in API
Filings indexed 369 across all filing types
Latest filing 2021-09-17 Regulatory Filings
Country US United States of America
Listing US TYRA

About Tyra Biosciences, Inc.

https://tyra.bio/

Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines. The company specializes in therapies targeting fibroblast growth factor receptor (FGFR) biology, aiming to overcome tumor resistance and address key drivers of disease. Utilizing its proprietary SNÅP Discovery Engine, Tyra Biosciences designs innovative molecular structures. Its lead clinical program involves the development of oral dabogratinib for the treatment of skeletal dysplasia and urologic cancers.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, which reports on specific corporate events. The content includes amendments to the articles of incorporation and bylaws, details about the IPO closing, and related corporate governance changes. It does not contain full financial statements or comprehensive financial performance data typical of annual or quarterly reports. It also does not fit into categories like earnings release, audit report, or management discussion. The primary focus is on corporate governance changes and a significant financing event (IPO completion). However, since the document is a current report (8-K) detailing corporate events and amendments rather than a detailed capital/financing update or management information report, the best fitting category is Regulatory Filings (RNS), which serves as a general category for miscellaneous SEC filings that do not fit other specific categories.
2021-09-17 English
S-8
Share Issue/Capital Change Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Tyra Biosciences, Inc. Form S-8 is used to register securities to be offered under employee benefit plans such as stock option plans and employee stock purchase plans. The document includes details about the securities to be registered, the plans under which they are offered, indemnification provisions, and incorporation by reference of other filings. It is not a financial report, earnings release, or management discussion, but a registration statement related to share issuance under employee plans. This fits the definition of a Share Issue/Capital Change announcement, as it relates to new share issuances under equity incentive plans and employee stock purchase plans.
2021-09-15 English
424B4
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus for an initial public offering (IPO) of common stock by Tyra Biosciences, Inc. It includes extensive information about the offering, risk factors, financial data, management discussion and analysis, business overview, management, executive compensation, and other related sections typical of a registration statement or prospectus filed under SEC rules. The presence of 'Filed Pursuant to Rule 424(b)(4)' and detailed offering terms confirms this is a securities offering prospectus. This type of document is not an annual report, earnings release, or any other financial report but a capital markets filing related to financing and share issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the full prospectus, not just an announcement or summary.
2021-09-15 English
Regulatory Filings 2021
Regulatory Filings
2021-09-15 English
FORM 3 SUBMISSION
Director's Dealing
2021-09-15 English
FORM 3 SUBMISSION
Director's Dealing
2021-09-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.